GILLIAN C IVERS-READ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GILLIAN C IVERS-READ.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GILLIAN C IVERS-READ. GILLIAN C IVERS-READ is a Vice President in PHARMION CORP ($PHRM) and a VP, Clin. Dev. & Reg. Affairs in PHARMION CORP ($PHRM) and a VP-Clinical Dev.& Reg. Affairs in PHARMION CORP ($PHRM) and a Director in BIO-PATH HOLDINGS INC ($BPTH) and a See Remarks in Clovis Oncology, Inc. ($CLVS).

Address: C/O PHARMION CORPORATION 2525 28TH STREET BOULDER 80301 CO

Companies in which GILLIAN C IVERS-READ is an Insider

BIO-PATH HOLDINGS INC

Trading Symbol: BPTH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 17 2011
$BPTH Market Capitalization: $81.31M
$BPTH Previous Close: $0.86

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Clovis Oncology, Inc.

Trading Symbol: CLVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: See Remarks
Holdings: 248,828 shares
Current Value: $14,929,680
Latest Transaction: May 04 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PHARMION CORP

Trading Symbol: PHRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: VP-Clinical Dev.& Reg. Affairs, VP, Clin. Dev. & Reg. Affairs, Vice President
Holdings: 0 shares
Latest Transaction: Dec 14 2005

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of GILLIAN C IVERS-READ

Sentiment: All, BPTH, CLVS, PHRM

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 04 2021CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksOption ExerciseM0.004,625050,875
May 04 2021CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksOption ExerciseM0.003,749026,245
May 04 2021CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksSellS5.542,18312,094249,501251.7 K to 249.5 K (-0.87 %)
May 04 2021CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksBuyM0.004,6250251,684247.1 K to 251.7 K (+1.87 %)
May 04 2021CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksSellS5.541,7699,800247,059248.8 K to 247.1 K (-0.71 %)
May 04 2021CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksBuyM0.003,7490248,828245.1 K to 248.8 K (+1.53 %)
Dec 23 2020CLVSClovis Oncology, I ...IVERS-READ GILLIAN CSee RemarksOption ExerciseM0.001,87500

View all GILLIAN C IVERS-READ insider transactions.